Table I. Studies focused on cannabinoids as potential agents against pancreatic cancer as classified by different experimental systems, cannabinoid receptors, and their effects.

AMPK: AMP-activated protein kinase; CB1: cannabinoid receptor 1; CB2: cannabinoid receptor 2; NR: not reported; PTEN: phosphatase and tensin homologue; ROS: reactive oxygen species.